Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × Tamoxifen × Clear all

Phase

Phase 3 21 Phase 2 4 Phase 1 1

Status

Sponsor Class

OTHER 13 INDUSTRY 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Cisplatin 20 Radiotherapy 15 Paclitaxel 15 Carboplatin 15 Cyclophosphamide 13 Vincristine 12 Etoposide 11 Filgrastim 10 Doxorubicin 10 Gemcitabine 9 Docetaxel 8 Topotecan 7 Dexamethasone 7 Temozolomide 6 Granulocyte Colony-Stimulating Factor 6 Cytarabine 6 Radiation 5 Peripheral Blood Stem Cell Transplantation 5 Oxaliplatin 5 Methotrexate 5 Melphalan 5 Fenretinide 5 Capecitabine 5 etoposide phosphate 4 Trastuzumab 4 Taxes 4 Radiotherapy, Conformal 4 Pemetrexed 4 Leucovorin 4 Lapatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00424164 2024-03-08

LAPATAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡